China Sxt Pharmaceuticals Inc (SXTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,304 | -3,099 | -5,935 | -5,736 | -2,748 |
| Depreciation Amortization | 82 | 203 | 250 | 320 | 345 |
| Income taxes - deferred | N/A | N/A | N/A | 328 | -193 |
| Accounts receivable | -257 | -321 | 913 | 832 | -519 |
| Accounts payable and accrued liabilities | -114 | -29 | 10 | -23 | -620 |
| Other Working Capital | -972 | -382 | 1,416 | 1,903 | -1,606 |
| Other Operating Activity | 2,219 | 1,700 | 3,266 | 2,645 | 4,024 |
| Operating Cash Flow | $-2,345 | $-1,928 | $-81 | $268 | $-1,317 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 64 | -7 | -71 | -63 | -93 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -8,845 |
| Other Investing Activity | 0 | 34 | 58 | 16 | 3,133 |
| Investing Cash Flow | $64 | $26 | $-12 | $-47 | $-5,806 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,692 | -708 | 4,031 | 2,805 | N/A |
| Debt Repayment | -1,918 | -79 | -26 | -33 | -83 |
| Common Stock Issued | N/A | N/A | N/A | 3,115 | N/A |
| Other Financing Activity | 2,625 | -1,838 | -1,063 | -4,292 | 12,492 |
| Financing Cash Flow | $8,399 | $-2,624 | $2,942 | $1,595 | $12,410 |
| Exchange Rate Effect | -65 | -765 | -1,050 | 394 | 785 |
| Beginning Cash Position | 12,077 | 17,369 | 15,570 | 13,359 | 7,287 |
| End Cash Position | 18,129 | 12,077 | 17,369 | 15,570 | 13,359 |
| Net Cash Flow | $6,052 | $-5,291 | $1,799 | $2,211 | $6,072 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,345 | -1,928 | -81 | 268 | -1,317 |
| Capital Expenditure | -2 | -7 | -71 | -63 | -93 |
| Free Cash Flow | -2,347 | -1,935 | -152 | 206 | -1,410 |